New reports put India's Torrent at forefront of buyers for Elder Pharmaceuticals

The rumors were that Sanofi ($SNY), Novartis ($NVS) and GlaxoSmithKline ($GSK) were all taking a close look at India's Elder Pharmaceuticals as a way to beef up emerging market sales. But The Economic Times now says Elder is deep into discussions with Indian drugmaker Torrent Pharma, which is talking about 1,700 crore ($291 million) for its peer. Torrent has cash on hand, while Elder is debt-heavy. Sources tell the publication that it is most interested in Elder's women's health group. Story | More

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.